It is worth noting that this regulation is conserved in human malignancies, since the two proteins are significantly co-expressed in human CRCs, thus representing a potential therapeutic window for tumor-selective targeting of BRAF-driven colorectal malignancies [12]. The gene discussed is BRAF; the disease is neoplasm.